These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1520959)

  • 1. In vitro activity of antifungal agents against clinical isolates of aspergilli.
    Otcenásek M
    Zentralbl Bakteriol; 1992 Jun; 277(1):100-5. PubMed ID: 1520959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
    Berthet N; Faure O; Bakri A; Ambroise-Thomas P; Grillot R; Brugère JF
    J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
    Otcenásek M
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):129-34. PubMed ID: 2170505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility testing in Aspergillus species: an update.
    Lass-Flörl C
    Future Microbiol; 2010 May; 5(5):789-99. PubMed ID: 20441550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
    Karaarslan A; Arikan S; Ozcan M; Ozcan KM
    Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
    Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
    Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antifungal activity of natamycin toward molds isolated from commercially manufactured poultry feed.
    Brothers AM; Wyatt RD
    Avian Dis; 2000; 44(3):490-7. PubMed ID: 11006995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro resistance of Candida species to antifungal agents].
    Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
    Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
    Guinet R; Mazoyer MA
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmenting the activity of antifungal agents against aspergilli using structural analogues of benzoic acid as chemosensitizing agents.
    Kim JH; Campbell BC; Mahoney N; Chan KL; Molyneux RJ; Balajee A
    Fungal Biol; 2010 Oct; 114(10):817-24. PubMed ID: 20943191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates of fungi to saperconazole.
    Otcenásek M
    Mycopathologia; 1992 Jun; 118(3):179-83. PubMed ID: 1528231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.